细胞治疗服务提供商
2023.12.01, 阿斯利康
2023.08.01, Vivo Capital, Adage Capital Management, Exome Asset Management, Janus Henderson Investors, Logos Capital, 奥博资本, Pivotal Life Sciences, RA Capital Management, TCGX
2021.01.01，
2020.10.01, 威灵顿, 奥博资本, 晨兴创投, Vivo Capital, Temasek淡马锡, 礼来亚洲基金, King Star Med LP
2019.02.26, Temasek淡马锡, 礼来亚洲基金, 翼朴资本, King Star Capital, 成都妙济
2019.02.01, Temasek淡马锡, King Star Capital, 礼来亚洲基金, 翼朴资本, 苏民投, 成都妙济
Note: collected from public online reports, for reference only.
